For LDL-C levels below 55 mg/dL there was an 18% risk reduction for both all-cause dementia and ADRD. In those with LDL-C ...

Adults with high or even low levels of LDL (bad) cholesterol who took statins lowered their risk of dementia in a new study.

Over the years, there have been significant changes to the dyslipidemia medication management guidelines, alongside ...

Statin use does not affect survival outcomes for ALS patients, so there may be no need to stop taking them after a diagnosis, ...

Could cholesterol drugs also protect against liver cancer? A new study reveals surprising results for a specific class of ...

Here's why one generic for Lipitor and other recognizable brands may have missed the mark compared to its recognizable ...

Now, a study has found that low levels of LDL-C, or ‘bad’ cholesterol, may reduce the risk of developing dementia. Statins, a ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

In the early Noughties, "cholesterol" became a bit of a buzzword, with campaigns and advertisements telling us we should care ...

AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a midstage trial, boosting hopes for a potential blockbuster that could be part of a powerful combination ...

Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...

AstraZeneca’s new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.